Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary

Shyam Poludasu1, Jonathan D Marmur, Jeremy Weedon

  • 1Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203-2098, USA.

Thrombosis and Haemostasis
|September 1, 2009
PubMed

Insights

High red cell distribution width (RDW) predicts mortality in patients after percutaneous coronary intervention (PCI), especially those without anemia. This finding highlights RDW

Area of Science:

  • Cardiology
  • Hematology

Background:

  • Red cell distribution width (RDW) is an established mortality predictor in coronary artery disease and heart failure.
  • The prognostic value of RDW in patients undergoing percutaneous coronary intervention (PCI) requires further investigation.

Purpose of the Study:

  • To evaluate the prognostic utility of RDW in predicting long-term mortality in patients who underwent PCI.
  • To explore the interaction between RDW and hemoglobin (Hgb) levels in this patient cohort.

Main Methods:

  • Retrospective analysis of 859 patients undergoing PCI between January 2003 and August 2005.
  • RDW categorized into low, medium, and high groups using empirically determined cutoffs (13.3% and 15.7%).
  • Multivariate analysis assessing the independent predictive value of RDW for mortality, considering interactions with Hgb levels.

Main Results:

  • A total of 95 (11%) deaths occurred during a median follow-up of 4 years.
  • Higher RDW was a significant univariate predictor of mortality (p < 0.001).
  • RDW was not an independent predictor in patients with Hgb <10.4 g/dL. However, in patients with Hgb >10.4 g/dL, high RDW strongly predicted mortality (HR 5.2-8.6 compared to low RDW).

Conclusions:

  • RDW is a strong and independent predictor of long-term mortality in non-anemic patients undergoing PCI.
  • The prognostic impact of RDW is significantly influenced by baseline hemoglobin levels.
  • RDW may serve as a valuable risk stratification tool in patients post-PCI.

Related Concept Videos